What is Mirum Pharmaceuticals, Inc.'s stock issuance proceeds?

Mirum Pharmaceuticals, Inc. (MIRM) reported stock issuance proceeds of $10.13M in Q1 2026.

How has Mirum Pharmaceuticals, Inc.'s stock issuance proceeds changed year-over-year?

Mirum Pharmaceuticals, Inc.'s stock issuance proceeds increased by 59.3% year-over-year, from $6.36M to $10.13M.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Mirum Pharmaceuticals, Inc. MIRM Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Gilead SciencesGILD

$166M-34.1%

Arrowhead ResearchARWR

$46.83M—

AlkermesALKS

$15.71M-46.8%

Ionis PharmaceuticalsIONS

$57.3M+2,457%

Rhythm Pharmaceuticals, Inc.RYTM

——

LQD

Liquidia CorporationLQDA

——

Other financials

Income statement

See full

Revenue$159.9M+43.3%

Operating income-$789.5M-5,100%

Net income-$790.2M-5,284%

EPS (diluted)-$13.43-4,377%

Balance sheet

See full

Cash & equivalents$261.5M+43.5%

Total debt$13.5M+56.4%

Total equity$242.5M+4.0%

Total assets$890.9M+29.1%

Cash flow

See full

Operating cash flow-$228.8M-11,566%

CapEx$664.0K+1,520%

Free cash flow-$229.4M-11,360%

Valuation

See full

Market cap$6.53B+152%

Enterprise value$6.28B+162%

P/S11.5×+4.6×

Profitability

See full

Operating margin-139.8%-168pp

Net margin-140.2%-169pp

FCF margin-30.3%—

Returns & leverage

See full

Return on equity-335.8%-377pp

Debt / equity0.1×0.0×

Current ratio2.1×-1.1×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirum Pharmaceuticals, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Mirum Pharmaceuticals, Inc.'s stock issuance proceeds?: Mirum Pharmaceuticals, Inc. (MIRM) reported stock issuance proceeds of $10.13M in Q1 2026.
How has Mirum Pharmaceuticals, Inc.'s stock issuance proceeds changed year-over-year?: Mirum Pharmaceuticals, Inc.'s stock issuance proceeds increased by 59.3% year-over-year, from $6.36M to $10.13M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.